Product Information

OXCARBAZEPINE ER 600 MG TABLET is a generic product labeled by Ajanta Pharma USA Inc., priced at $8.7702 per EA under NDC 27241023901. Its NADAC has been published 68 times since Aug 6, 2025.

FDA first approved this application on Feb 22, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the Oxcarbazepine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

OXCARBAZEPINE ER 600 MG TABLET

Oxcarbazepine
$8.7702per EA
High Outlier

Strength

600 mg/1

NDC

27241023901

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

OXCARBAZEPINE

Approval Type

Generic (ANDA)

FDA Application

ANDA217659

FDA Approved

2/22/2024

TE Code

AB

On Market Since

2/22/2024

Pharmacological Classes

Anti-epileptic Agent
Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for OXCARBAZEPINE ER 600 MG TABLET has been published 68 times since Aug 6, 2025, and over the history we have for it it has declined 49.3%. The table below summarizes its recorded NADAC range and movement.

Current price$8.7702 per EA
All-time high$17.4978 (Sep 10, 2025)
All-time low$8.7702 (Nov 18, 2026)
52-week high$15.3208
52-week low$8.7702
Median price$11.9498
Average price$12.7721
Largest weekly change-12.5% (Feb 18, 2026)
Weeks tracked68
Tracking sinceAug 6, 2025

Price History

1W

-6.5%

1M

-8.4%

3M

-7.5%

6M

-20.2%

1Y

-42.5%

3Y

N/A

5Y

N/A

All

-49.3%

Generic Alternatives

The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 96% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of OXCARBAZEPINE ER 600 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for OXCARBAZEPINE ER 600 MG TABLET, manufactured by Ajanta Pharma USA Inc., is $8.7702 per EA (NDC 27241023901), effective Nov 18, 2026.

How has the price of OXCARBAZEPINE ER 600 MG TABLET changed over time?

Over the history we have for it, the NADAC for OXCARBAZEPINE ER 600 MG TABLET has declined 49.3%. It has been tracked across 68 weekly CMS publications since Aug 6, 2025.

What are the highest and lowest recorded NADAC prices for OXCARBAZEPINE ER 600 MG TABLET?

Since Aug 6, 2025, the NADAC for OXCARBAZEPINE ER 600 MG TABLET has ranged from a low of $8.7702 (Nov 18, 2026) to a high of $17.4978 (Sep 10, 2025), with a median of $11.9498 per EA.

Are there cheaper alternatives to OXCARBAZEPINE ER 600 MG TABLET?

Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OXCARBAZEPINE 600 MG TABLET, is $0.3170 per EA — about 96% below OXCARBAZEPINE ER 600 MG TABLET.

Who manufactures OXCARBAZEPINE ER 600 MG TABLET?

OXCARBAZEPINE ER 600 MG TABLET (NDC 27241023901) is labeled by Ajanta Pharma USA Inc., and CMS classifies it as a generic product.